Læknablaðið : fylgirit - 01.08.2003, Qupperneq 5

Læknablaðið : fylgirit - 01.08.2003, Qupperneq 5
ABSTRACTS / 27TH NORDIC PSYCHIATRIC CONGRESS I ABSTRACTS N - NAPE N-1 Wednesday 13/8,10:10-10:30 The association between age and depression in the general population: a multivariate examination Eyslein Stnrdal MD, Helse Nord-Tr0ndelag HF, Hospilal Namsos, Department of Psychiatry, N-7800 Namsos, Norway. Arnstein Mykletun MA, Alv A. Dahl MD. PhD. Eystein.stordal@hu.no Background: In a large general population study we found a close to linear rise with age in the mean score and prevalence of self- reported symptoms of depression. Aims: To examine if this linear relation prevailed when controlled for multiple variables, and to examine what factors that eventually explained the association. Metliod: Among individuals aged 20-89 years living in Nord- Trpndelag County of Norway, 60869 l'illed in valid ratings of the Hospital Anxiety and Depression Scale (HADS) as well as ntany other variables. Covariates were grouped into a multivariate model with six blocks. Logistic regression was used to model the blocks and variables with caseness of depression as the dependent variable. Results: The ntodel explains a considerable part of the age-related pattern on depression. Tlie pattern becante less distinct in the age groups above 50 years. Variables within the blocks of somatic diagnoses and symptoms, as well as impairment, had most explana- tory power. Four blocks reduce the prevalence of depression signi- ficantly: Impairment, sociodemographics, somatic diagnosis and somatic symptoms. Eight single variables reduce the age-effect: Education, impairment caused by movement, hearing, vision and physical disease, physical activity, muscle skeletal disorders, and muscle skeletal symptoms. Conclusions: Due to our large sample we were able to control for more relevant variables than earlier studies. In contrast to most other studies, we found that an age-related increase of the preva- lence of depression persisted after control for multiple variables. N - 2 Wednesday 13/8,10:30-10:50 Epidemiology of old age in lceland 1 lull^ríniiir Magnússon. tlr med, Head of Department. Dept. of Psychiatry of Old Age, Ullevál University Hospital, Slottsbergen 35,1385 Asker, Norway hillgrimur@oslo.onlme.no Introduction: In Iceland a longitudinal epidentiological study of a birth cohort has been carried out. Tlte study covers almost the whole lifespan of every Icelander born in three consecutive years. The study based its case finding and diagnosis on extensive inter- views with the general practitioners in the country and on thorough review of medical records. This strategy was timely when it first appeared but in the Iast phase of the study it was supplemented with interviews of the subjects themselves using the Geriatric Mental State Schedule. Results: The prevalence of depression in Iceland was 7,9% and 8,7% al the age of 81 and 87 years respectively. Compared to similar studies in Europe, Iceland has the lowest prevalence. Iceland also has very low suicidal rate in old age compared to other countries. Pattern of depressive symptoms in the general population in Iceland differed considerably from similar data in other countries in Europe. Tlte prevalence of dementia in Iceland was 7,8 and 15,1 at the age of 81 and 87 years respectively. Several recent studies on the incidence rate of dementia show results similar to the Icelandic study. N - 3 Wednesday 13/8,11:10-11:30 Psychotropic use in the homedwelling elderly Sirpa Hartikainen. Clinical Lecturer, Kuopio University, Division of Geriatrics, Depart- ment of Public Health and General Practise, Finland sirpa. hartikainen @uku.fi Psychotropic use is common and becoming even more common among the elderly in Finland. This use includes lots of adverse effects, especially falls and cognition. Risks of interactions grow when using with several other medicines. The Kuopio 75+ Study is a population based health survey focused on epidemiology of medicine use and functional capacity among the elderly subjects aged 75 years or older. A random sample of 700 subjects was drawn from a total population aged at lcast 75 years and living in the city of Kuopio on January 1, 1998 (n=4518). A structured clinical examination and interview were carried out for 601 subjects (86% out of random sample) by a geriatrician and a trained nurse. Those living in institutions (n=78) were excluded; thus, 523 persons were subjects in this study. At least one psychotropic medicine was used by 37% of the elderly and 12% were using at least two psychotropics concomit- antly. Those using psychiatric medication were older, more often widowed, and living alone than non-users. The probability of psychotropic use increased linearly with age for anxiolytics/ hypnotics and for antipsychotics, but nol for antidepressants. Anxiolytics and hypnotics were most commonly prescribed psychotropic medicine (30%) and one-tenth was using antidepres- sant (11%) or antipsychotic medicine (9%). The demented person more often uses all kinds of psychotropic medicines than non-demented. One of four demented elderly com- pared to one in ten non-demented used at least two psychotropics. The demented elderly used antipsychotics six times more often than the non-demented and tended to use antidepressants more commonly as well. Among the non-demented elderly, one out of every two anti- psychotics (N=31) users was suffering from depression according to DSM IV criteria. However, at the same time most non-demented depressed persons (N=79, 68%) were not receiving any anlide- pressant medication. Condusion: Prescription practice that most commonly gives psychotropic medication to the oldest and most vulnerable ones includes high risks of adverse effects and interactions. It seems thal the threshold to prescribe antipsychotics to the elderly is low. The Læknablaðið / FYLGIRIT 4S 2003/89 5
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.